☆Fairmount Funds Management LLC
Quality Q
0.880
AUM ($M)
1,513
Positions
12
Turnover
0.18
Top-10 wt
98%
Herfindahl
0.139
History (qtrs)
6
Excess Return
+57.9%
AI Eval Run AI Eval
Holdings · 13 positions · portfolio value $1,513M
| Ticker | Name | Activity | Security Type | Weight | Δ Weight | Value ($M) | Shares | Δ Shares | Qtrs Held | Excess Return |
|---|---|---|---|---|---|---|---|---|---|---|
| ☆ORKA funds › | ORUKA THERAPEUTICS INC | HOLD | — | 23.3% | +10.2% | 352.6 | 3,705,262 | +0 | 5 | — |
| ☆DNTH funds › | DIANTHUS THERAPEUTICS INC | HOLD | — | 16.3% | +1.0% | 247.3 | 2,537,191 | +0 | 5 | — |
| ☆DMRA funds › | DAMORA THERAPEUTICS INC | HOLD | — | 15.0% | -1.3% | 226.6 | 8,713,000 | +0 | 2 | -23.6% |
| ☆COGT funds › | COGENT BIOSCIENCES INC | HOLD | — | 14.1% | -1.2% | 213.0 | 5,503,418 | +0 | 5 | — |
| ☆JBIO funds › | JADE BIOSCIENCES INC | HOLD | Common Stock | 6.7% | +2.1% | 101.2 | 4,553,494 | +0 | 5 | +139.5% |
| ☆ELVN funds › | ENLIVEN THERAPEUTICS INC | HOLD | — | 6.2% | +1.0% | 94.2 | 1,855,644 | +0 | 5 | — |
| ☆VRDN funds › | VIRIDIAN THERAPEUTICS INC | ADD | — | 6.2% | +0.7% | 93.5 | 5,090,928 | +1,176,470 | 5 | — |
| ☆ZBIO funds › | ZENAS BIOPHARMA INC | HOLD | — | 4.0% | +0.6% | 59.9 | 2,359,025 | +0 | 5 | — |
| ☆CBIO funds › | CRESCENT BIOPHARMA INC. | HOLD | — | 3.3% | -0.4% | 49.5 | 2,747,866 | +0 | 5 | -51.5% |
| ☆APGE funds › | APOGEE THERAPEUTICS INC | HOLD | — | 2.6% | +0.8% | 39.6 | 298,647 | +0 | 5 | — |
| ☆FTH funds › | FAETH THERAPEUTICS INC | NEW | — | 1.2% | +1.2% | 18.1 | 722,020 | +722,020 | 1 | +624.6% |
| ☆IKT funds › | INHIBIKASE THERAPEUTICS INC | HOLD | — | 1.2% | +0.1% | 17.5 | 8,625,000 | +0 | 5 | — |
| ☆SYRE funds › | SPYRE THERAPEUTICS INC | EXIT | Common Stock | 0.0% | -14.6% | 0.0 | 0 | -4,018,101 | 0 | — |
Point-in-time history
| Period | AUM ($M) | Positions | Turnover | Top-10 wt | Herfindahl | Quality Q | Skill | Universe |
|---|---|---|---|---|---|---|---|---|
| 2026Q2 | 1,513 | 12 | 0.18 | 98% | 0.139 | 0.879 | — | in |
| 2026Q1 | 1,384 | 12 | 0.36 | 97% | 0.123 | 0.605 | — | in |
| 2025Q4 | 1,314 | 13 | 0.32 | 92% | 0.118 | 0.561 | — | in |
| 2025Q3 | 1,111 | 17 | 0.20 | 78% | 0.074 | 0.656 | — | in |
| 2025Q2 | 772 | 17 | 0.12 | 80% | 0.075 | 0.790 | — | entered |
| 2025Q1 | 645 | 15 | 0.00 | 87% | 0.087 | 0.000 | — | out |
Long US-equity 13F disclosures only · up to 45-day reporting lag · sells = reduce/avoid, not short.
JSON: /api/signals ·
/api/funds ·
/api/status